0001209191-23-030950.txt : 20230519
0001209191-23-030950.hdr.sgml : 20230519
20230519160512
ACCESSION NUMBER: 0001209191-23-030950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Squarer Ron
CENTRAL INDEX KEY: 0001454001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36257
FILM NUMBER: 23939989
MAIL ADDRESS:
STREET 1: C/O ADC THERAPEUTICS SA
STREET 2: BIOPOLE, ROUTE DE LA CORNICHE 3B
CITY: EPALINGES
STATE: V8
ZIP: 1066
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Travere Therapeutics, Inc.
CENTRAL INDEX KEY: 0001438533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262383102
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 888-969-7879
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Retrophin, Inc.
DATE OF NAME CHANGE: 20130220
FORMER COMPANY:
FORMER CONFORMED NAME: Desert Gateway, Inc.
DATE OF NAME CHANGE: 20080625
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-17
0
0001438533
Travere Therapeutics, Inc.
TVTX
0001454001
Squarer Ron
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
0
Common Stock
2023-05-17
4
A
0
4500
0.00
A
22375
D
Stock option (right to buy)
17.11
2023-05-17
4
A
0
13500
0.00
A
2024-05-17
2033-05-16
Common Stock
13500
13500
D
Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
The equity award vests over a one year period.
/s/ Elizabeth E. Reed, Attorney-in-Fact
2023-05-19